Member Info for TroytoTiber

Back in profit. Debt falling and Outlook still good. Whilst demand locally for gas has been sluggish, and with geec having to hold back gas for SAIL which hasn't been taken it has meant that flaring of gas has been up to 30% of production. However the new pipeline to kolkata will be complete by the end of 2019 meaning that all surplus gas can be sold into this demand from further afield. We might just finally be on the t hreshhold of exciting times. Current (post year end) gas sales run rate at around 15m cubic feet per day now so suspect that next year full year sales gas will be around 16m cubic feet per day. Debt begins to get paid down quite uickly at this level of sales assuming prices hold. On that, sales prices up over the year by high single digits. Significant appreciation in the share price over next 18 to 24 months at current rate of improvements.

Fixed costs such as buildings and running costs will be built into the funding so there will be more cash to cover these (ie profit on the contract) also be able to use some redundancy time with one or two employees if there is any. So it makes for a small positive from that perspective as well. Agree that the more meaningful element is the in with the NHS though.

Looks good. All it needs now is a positive update on take up of hcv tests and genedrive unit sales and we should get some share price progress to match the operational progress. I revisited the website to have a nose around for anything new and reread the capital network research note that genedrive have put up on their site. It reads pretty clearly that there will be a capital raise in h2 even with the sale of services division. Can only assume that genedrive management are happy for market to know that as they made this research note avaliable. Would help explain why the shares are going nowhere. Most likely therefore some dilution headed our way soon. My best guess would be a share issue arranged with a couple of large institutions and maybe the take up of kath booths shareholding into the deal. Once all that has washed through then I think we can look forward to some interesting times. Thoughts?

Thanks both for the comments. I really just referring to the fact that over the last few weeks or even months it has been very easy to buy large volumes (ie50k +) and well inside the spread and that situation hasn't seemed to change over time. So I'm assuming that there is a large open order that is filling the sporadic buys and will continue to do so until it's largely gone without allowig the sharessential to shift up much. Appreciate the points about the share price rises and no interest in the bid until after Monday though.

Well, my initial enthusiasm has been tempered a smidge. Went online to top up and discovered that I could buy up to 50k shares at 36.7p now but I couldn't even sell 1k shares without a negotiated order! Market makers practically falling over themselves to sell these to us and absolutely do not want any more stock. As we've discussed many times, the news flow is all good so far but there is still a large block of available stock out there that MMs know about and so until this is soaked up I can't see the share price going anywhere unfortunately

These 37p trades look like buys not sells to me. I'm going to be deliberately and unapologetically optimistic and say that the increase in size and frequency of these buys bodes well for the future! Happy Wednesday!

Management continue to deliver everything that they say they will. Credibility going up around this team in my view. First commercial sales of tb tests in h2 2019 as stated by management then becomes very interesting if we assume that they continue to only make statements about things they feel confident they can deliver. Wider market clearly not willing to price that 18 month prospect in yet, not even one based only on hcv. Once repeatable sales are demonstrated and growing the prospect of surplus cash flows has to bring renewed interest here. I think these guys are worth backing therefore. Suspect there will be plenty of interest in Dr booths shares once lock up is over.

Yep good to see thanks ctw. Not an rns that is on the lse site here but it's there on the genedrive website. Decent accumulation of stock. Being invested in genedrive is making me realise how much of an instant gratification modern day consumer I've become. Being confidently patient is not an easy thing for me here. I'm like a weasel in a sealed up sack!

Either everyone else who was on this board has sold up and moved on or that lengthy silence means no one managed to go. Bit of a shame.

I can't make the investor show in London this Saturday unfortunately but would love to hear feedback from any gdr holders on this board who do get to the event and spend a bit of time questioning the management.

We really do need some buys! A lot of of them! I can still buy a large quantity of these and can't sell in any size above 2000 shares. It could well be that the mm know that Odey are still sellers in size. If so the share price is likely to drift from here again without a big buyer. Frustrating as the news has been good of late! One day Rodders we'll be millionaires.....

Bang on there ctw. Still looks like there is block of stock around that the market makers know about in addition. Needs quite a bit more buying pressure to get this moving to my mind.

So these larger buy orders that have kept slipping in over the last few weeks are keeping my mood buoyant!

Good to see and ahead of the results which is odd unless they had no choice. If developments are so material then they may have felt that they had to report this now! Just speculation on rns timing from me. Anyway see this as further good news on execution of strategy and pathway to a significantly more valuable company than the current share price. Interesting also that the large 41k buy snook in just ahead of this rns. AIM no longer sur prises me with its insider dealing so let's see just take this for what it is....someone with additional info to us taking a sizeable amount of stock because they knew how significant this rns is.

No the update that was expected. Unclear whether these sales will now return. Still a sales growth story for geec but maybe given the nature of this growth it might be more prudent to use a higher discount rate. Question now is can the management deliver production and sales growth and reduce the required cost of capital for investors. It's been many years of not achieving this.

More record production volumes being tweeted but sail durgapur. Looking increasingly likely that production reliability issuses are being resolved there. Could result in an extra 3 to 5 mmcfd of sales gas to geec. Be good to hear from the company ahead of the year end March 31st.

Good news indeed. Slightly increases the chances of commercialising tb which would transform this company as long as it was a solution that healthcare systems wanTed to buy. However if it allows subsidies to be by passed and it's accurate and reliable then there shouldn't be much to stop it. Wonder how long it will take them to modify the tb tests? And then get them to market?

Reporting on Twitter that record steel production achieved in Feb. This has to mean increased gas volumes used and should result in GEEC reporting increased sales gas volumes. Confidence building in 20 mmcfd run rate at next update. Existing 150 Wells drilled and producing/dewatering will deliver peak production of around 35 to 40 mmcfd. Once this sales gas level achieved just these wells are worth around 250p at current gas prices. Cash flows can then fund the other 150 Wells and begin to pay a dividend. If executed without problems we are looking at a share price between 400m and 500p in 3 to 4 years time as this expansion is delivered and cashflows are derisked. Not as cheap as it was given the recent share price run but still good value.

I think that this would relate to when epistem under old managementioned team took the newly developed genedrive unit for testing with becton dickinson in the US and it failed spectacularly. Faith in any commercial realisation at that point plummeted. Different story now though. (I hope!)

Complete waste of time. Nothing new. Would like to have seen some mention of sales but guess its still early in the quarter. Why not wait a few weeks and post the update when there's something good to say I wonder? On a seperate note, the 250k pur chase will need to be disclosed by any institution that had a prior disclosable holding being 1.3% of the issued share capital. No rns on that then it's a new investor or someone with a previously small holding.